Kristen Fortney | CEO
BioAge Labs

Kristen Fortney, CEO, BioAge Labs

Dr. Kristen Fortney is the Chief Executive Officer of BioAge Labs, a venture-backed computational biology startup in Berkeley, California. BioAge Labs was founded in 2015 and couples genomic data with machine learning to measure human aging and accelerate drug discovery. Dr. Fortney received her PhD in Medical Biophysics from the University of Toronto in 2012, and completed her postdoctoral training at Stanford University, where she was a postdoctoral fellow of the Ellison Medical Foundation / American Federation for Aging Research. She is an expert at developing novel bioinformatics approaches that harness large amounts of data to shed light on mechanisms of aging and age-related disease. Her research has focused on computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.



BioData West: Day 1 @ 15:40

Molecular signatures of human mortality: biomarkers and therapies

  • Accelerating drug testing by developing molecular signatures of mortality
  • Attaining the best signatures by deeply phenotyping large human cohorts┬á
  • High-throughput omics data, coupled with innovative machine learning, is revealing new biomarkers and drug targets

back to speakers